Key Principle
Capital has a profile that determines whether it enables or kills disruptive innovation. "Good money" is patient for growth but impatient for profit. "Bad money" is impatient for growth but patient for profit. Impatience for profit forces three behaviors: (1) quickly testing whether customers will pay profitable prices, (2) keeping fixed costs low so disruptive customers remain attractive, (3) insulating the venture from corporate cutbacks when the core business stumbles. Patience for growth permits competing against nonconsumption and following emergent strategy. (Chapter 9)
Why This Matters
A self-reinforcing death spiral converts good money into bad money. First, a growth gap emerges as Wall Street discounts expected growth. Good money becomes impatient for growth -- only initiatives promising to get very big very fast pass the resource allocation filter, killing disruptive proposals. Executives then tolerate losses because competing against consumption in large markets is expensive; cost structure is put in place before revenue. Losses precipitate retrenchment, new management refocuses on core, the growth gap widens, and the loop repeats. (Chapter 9)
The data is stark: of 172 Fortune top-50 companies studied from 1955-1995 (Stall Points study), 95% saw growth stall and only 4% reignited growth above GNP plus 1%. Once the spiral starts, recovery is nearly impossible. This explains why getting initial conditions right matters so much -- the margin for correction is vanishingly small.
Good Examples
- Honda's U.S. motorcycle entry: Total investment of $250K ($110K cash) forced emergent strategy. Unable to subsidize losses on large bikes, Honda pivoted to 50cc Super Cubs sold through sporting goods shops -- discovering the off-road recreational new-market disruption that conquered the industry. Had Honda entered with ample capital, it would have persisted with its failing deliberate strategy of selling large bikes through motorcycle dealers. Scarcity was the enabling constraint. (Chapter 9)
- J&J's MDD group: Acquired four disruptive businesses (Ethicon Endo-Surgery, Cordis, Lifescan, Vistakon) that grew at 43% annually since 1993, reaching approximately $10B. Non-disruptive MDD businesses grew at 3%. Consumer group's sustaining acquisitions grew at 4%. Systematic disruption, started early and kept small, produced an order-of-magnitude growth advantage. (Chapter 9)
- Three policies for keeping the growth engine running: (1) Start early -- launch disruptive businesses in a predetermined rhythm while the core is healthy, because reaction is too late. (2) Start small -- keep units small so that small opportunities remain attractive (a $1B unit needs $150M new business; a $20B monolith needs $3B). (3) Demand early success -- minimize subsidization to accelerate emergent learning and insure against core-business cutbacks. (Chapter 9)
Counterpoints
- Late 1990s VC funds: Firms that succeeded with small investments took in massive new capital, changed their values (needing huge wins to move the needle), and became the cause of the bubble rather than its victim. Good money became bad money through success-driven scale. (Chapter 9)
- The growth-gap trap: When the core business is large and growth is stalling, only multi-billion-dollar opportunities pass the filter. Disruptive proposals that would be attractive to a small unit get killed because they cannot promise enough revenue fast enough. The very scale that creates the urgency for growth makes growth-creating investments impossible to fund. (Chapter 9)
- Tolerating losses in pursuit of scale: Competing against established consumption in large existing markets requires massive upfront investment before revenue. This inverts the good-money profile -- the venture becomes patient for profit and impatient for growth, the exact combination that kills disruption. (Chapter 9)
Key Quotes
"When you start a new growth business, there is a ticking clock behind you. The problem is that this clock ticks at a variable rate that is determined by the health of the corporate bottom line, not by whether your little venture is on plan." -- Christensen & Raynor, Chapter 9
"There is nothing like profitability to ensure that a high-potential business can continue to garner the funding it needs, even when the corporation's core businesses turn sour." -- Christensen & Raynor, Chapter 9
Rules of Thumb
- Fund disruptive ventures with money that is patient for growth but impatient for profit -- never the reverse.
- Launch disruptive businesses while the core is healthy; if you wait until you need growth, the money will have the wrong profile.
- Keep venture units small enough that small market opportunities remain exciting rather than irrelevant.
- Demand early profitability not as a performance test but as a survival mechanism -- profitable ventures survive corporate downturns.
- If your venture requires years of losses before revenue, you are competing against consumption with bad money; reframe toward nonconsumption.
Related References
- Managing the Strategy Development Process - Emergent strategy requires patient-for-growth capital to permit pivots
- Organizational Capability and Disruptive Growth - Corporate values (size thresholds) are the mechanism that converts good money to bad
- Law of Conservation of Attractive Profits - Profit migration patterns determine where growth investments should be directed